Antithrombotic therapy for venous thromboembolic disease.
Hyers
T M
TM
Hull
R D
RD
Weg
J G
JG
D000284:Administration, Oral; D002986:Clinical Trials as Topic; D003362:Cost-Benefit Analysis; D016903:Drug Monitoring; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use*; D006801:Humans; D012307:Risk Factors; D013923:Thromboembolism / Q000188:drug therapy* / Q000191:economics; D015912:Thrombolytic Therapy / Q000191:economics; D013997:Time Factors
D005343:Fibrinolytic Agents